Karen is currently Senior Director in Drug Safety & Public Health for Gilead Sciences International Ltd. Up until April 2014 she also held the QPPV role at Gilead. She has worked for over 20 years in the pharmaceutical industry, the majority of those in pharmacovigilance. Her other experience includes clinical pharmacology, Phase II & III clinical trials and regulatory documentation.